Abstract
Mycobacterial infections (particularly, tuberculosis caused by Mycobacterium tuberculosis) represent a significant threat to public health, especially south of the Sahara. The problem has been compounded by poor patient compliance due to long periods of treatment, thus resulting in the development of multi-drug resistant (MDR) and extremely drugresistant (XDR) forms the of bacterium. It has, therefore, become imperative to seek new drugs from unexplored sources against these infections. Natural products, from ancient times, have often been used as drugs for the treatment of various ailments. They have also served as templates for the design and synthesis of new drugs. In sub-Saharan Africa particularly, ethnobotanical and ethnomedical knowledge of plants has been exploited to manage several different ailments, including tuberculosis. Thus research efforts have often been concentrated on plants as a source of treatment of diseases as well as drug leads. In this mini review, we report the biological activities of compounds derived from African medicinal plants with the potential for the treatment of anti-mycobacterial infections. Seventy nine (79) antimycobacterial compounds have been identified in sub-Sahara Africa covering the period from 1995 to 2013.
Keywords: Drug discovery, medicinal plants, mycobacterial infections, natural products, tuberculosis.
Anti-Infective Agents
Title:Potential Natural Antimycobacterial Metabolites from Some Sub-Saharan Medicinal Plants
Volume: 12 Issue: 2
Author(s): Joseph N. Yong and Fidele Ntie-Kang
Affiliation:
Keywords: Drug discovery, medicinal plants, mycobacterial infections, natural products, tuberculosis.
Abstract: Mycobacterial infections (particularly, tuberculosis caused by Mycobacterium tuberculosis) represent a significant threat to public health, especially south of the Sahara. The problem has been compounded by poor patient compliance due to long periods of treatment, thus resulting in the development of multi-drug resistant (MDR) and extremely drugresistant (XDR) forms the of bacterium. It has, therefore, become imperative to seek new drugs from unexplored sources against these infections. Natural products, from ancient times, have often been used as drugs for the treatment of various ailments. They have also served as templates for the design and synthesis of new drugs. In sub-Saharan Africa particularly, ethnobotanical and ethnomedical knowledge of plants has been exploited to manage several different ailments, including tuberculosis. Thus research efforts have often been concentrated on plants as a source of treatment of diseases as well as drug leads. In this mini review, we report the biological activities of compounds derived from African medicinal plants with the potential for the treatment of anti-mycobacterial infections. Seventy nine (79) antimycobacterial compounds have been identified in sub-Sahara Africa covering the period from 1995 to 2013.
Export Options
About this article
Cite this article as:
Yong N. Joseph and Ntie-Kang Fidele, Potential Natural Antimycobacterial Metabolites from Some Sub-Saharan Medicinal Plants, Anti-Infective Agents 2014; 12 (2) . https://dx.doi.org/10.2174/2211352512666140417002335
DOI https://dx.doi.org/10.2174/2211352512666140417002335 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti Inflammatory and Anti Arthritic Activity of Different Milk Based Formulation of Curcumin in Rat Model
Current Drug Delivery Subject Index to Volume 10
Current Pharmaceutical Design Designed Multiple Ligands: Basic Research vs Clinical Outcomes
Current Medicinal Chemistry Biosurfactants as a Novel Additive in Pharmaceutical Formulations: Current Trends and Future Implications
Current Drug Metabolism NMR Based Metabolomics: An Exquisite and Facile Method for Evaluating Therapeutic Efficacy and Screening Drug Toxicity
Current Topics in Medicinal Chemistry How Would Composite Traditional Chinese Medicine Protect the Brain – An Example of the Composite Formula “Pien Tze Huang”
Current Medicinal Chemistry Peroxiredons: Tryparedoxin Peroxidase from Leishmania major
Current Regenerative Medicine (Discontinued) Medicinal Chemistry of New Compounds to Treat Tuberculosis
Current Clinical Pharmacology The Implication of Pseudomonas aeruginosa Biofilms in Infections
Inflammation & Allergy - Drug Targets (Discontinued) Stem Cells in MDR-TB and XDR - TB
Current Respiratory Medicine Reviews Evidence-Based Management of Infertile Couples with Repeated Implantation Failure Following IVF
Current Women`s Health Reviews The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections
Current Drug Metabolism A Novel Feature-Significance Based k-Nearest Neighbour Classification Approach for Computer Aided Diagnosis of Lung Disorders
Current Medical Imaging Antitubercular Potential of Novel Isoxazole Encompassed 1, 2, 4- Triazoles: Design, Synthesis, Molecular Docking Study and Evaluation of Antitubercular Activity
Anti-Infective Agents Copper, An Ancient Remedy Returning to Fight Microbial, Fungal and Viral Infections
Current Chemical Biology Biologic Agents for Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial (Thematic Issue: Tropical Rheumatology)
Current Rheumatology Reviews Dendritic Cells and Macrophages: Same Receptors but Different Functions
Current Immunology Reviews (Discontinued) Increase of R-/S-Methadone Enantiomer Concentration Ratio in Serum of Patients Treated with Either Nevirapine or Efavirenz
Drug Metabolism Letters Inflammasome in Dendritic Cells Immunobiology: Implications to Diseases and Therapeutic Strategies
Current Drug Targets